Sharon Tetlow is chair of Dice Therapeutics’ audit committee and member of the company’s nominating and governance committee. She currently chairs the audit committee of public life sciences companies Valneva SE and Catalyst Biosciences. She also chairs the audit committee of ShouTi Pharma, a private biotech company based in South San Francisco and Shanghai China.
Since January 2016, Sharon has served as managing partner of Potrero Hill Advisors, which provides strategic and operational financial support to life science companies. She was previously a managing director with Danforth Advisors, and before that served as chief financial officer of public and private biotechnology companies.
Sharon holds a B.S. in psychology from the University of Delaware and an MBA from Stanford University.